Hong Kong's three major indices opened higher and extended gains throughout the trading session.

At the close, the Hang Seng Index was up 1.57% at 23,026.68, the Hang Seng Tech Index surged 3.23%, and the Hang Seng China Enterprises Index advanced 1.94%.

Across the board, technology and internet stocks mostly rose, with Lenovo Group Ltd falling over 9%, while NetEase, Inc. gained more than 6%.

Meituan, Baidu, Inc., and Bilibili Inc. all climbed over 5%, with Alibaba Group Holding Limited and JD.com, Inc. rising more than 3%.

Chip stocks saw a significant rally, with GigaDevice Semiconductor (Beijing) Inc. soaring over 14%.

Innovative drug concept stocks performed strongly, with RemeGen Co., Ltd. jumping more than 14%.

Robotics concept stocks were among the top gainers, with Horizon Robotics surging over 13%.

Three new listings debuted today: Libang Pharmaceutical Co., Ltd. - B surged over 103%, Haiguang Xinzheng rose more than 44%, and Baige Online Digital Technology Co., Ltd. skyrocketed over 367%.

Key Drivers for Chip Stocks

Chip stocks experienced a major upswing, led by GigaDevice Semiconductor (Beijing) Inc. which gained over 14%.

This follows news that Samsung officially announced an investment plan totaling 2,655 trillion Korean won (approximately 11.68 trillion yuan), with 2,030 trillion won earmarked for semiconductor cluster investments in Yongin and Pyeongtaek, South Korea.

Previously, South Korean sources indicated that Samsung Group and SK Hynix are set to announce major investment plans totaling 2,000 trillion won (approximately 8.8 trillion yuan) over the next decade, focusing on semiconductors, AI computing data centers, and physical AI fields.

Innovative Drug Sector Momentum

Innovative drug concept stocks showed robust strength, with RemeGen Co., Ltd. advancing more than 14%.

According to a notice from the National Healthcare Security Administration, 557 drugs passed the initial review for the national reimbursement drug list on June 29th, while 54 drugs passed the initial review for the commercial insurance innovative drug directory.

This marks the entry of the "national insurance + commercial insurance" dual-directory negotiations into a substantive phase, with newly introduced mechanisms such as pre-declaration and an eight-year price protection period also being implemented.

Robotics Stocks Lead Gains

Robotics concept stocks were at the forefront of the day's gains, with Horizon Robotics climbing over 13%.

Research from Guojin Securities suggests that 2026 is a critical inflection point for the humanoid robot sector, marking the transition from concept to initial commercialization.

The Tesla supply chain is expected to see the release of its first-generation mass-produced product within the year, with large-scale production anticipated to commence following the completion of major supply chain production lines.

For leading domestic players, shipment volumes are expected to scale from thousands to tens of thousands of units, with primary application scenarios including entertainment and commercial performances, scientific research and education, data collection, and guided tours and shopping.

At this stage, the supply chains and technologies of leading companies are expected to become more consolidated.

New Listings Debut

Three new stocks began trading today.

Libang Pharmaceutical Co., Ltd. - B surged over 103%, Haiguang Xinzheng rose more than 44%, and Baige Online Digital Technology Co., Ltd. skyrocketed over 367%.

During its public offering, Baige Online Digital Technology Co., Ltd. was oversubscribed by approximately 242.05 times, with the final number of shares offered to the public being 3.3346 million.

The public offering for Libang Pharmaceutical Co., Ltd. - B was oversubscribed by about 963.56 times, with the final public offering share count being 5.6756 million.

The public offering for Haiguang Xinzheng was oversubscribed by approximately 1,296.89 times, with the final public offering share count being 1.3432 million.